SLC37A4

UniProt ID: O43826
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

SLC37A4 (glucose-6-phosphate exchanger; G6PT/G6PT1) is a multi-pass endoplasmic reticulum membrane transporter of the SLC37 sugar-phosphate/phosphate exchanger family (major facilitator superfamily, organophosphate:Pi antiporter clade). It is the glucose-6-phosphate:inorganic-phosphate antiporter that translocates cytosolic glucose-6-phosphate (G6P) into the ER lumen in exchange for luminal inorganic phosphate. By importing G6P into the ER, it delivers the substrate to the luminal active site of the glucose-6-phosphatase catalytic subunits (G6PC1 in liver, kidney and intestine; G6PC3 ubiquitously, including neutrophils), and thereby carries out the terminal, glucose-releasing step shared by gluconeogenesis and glycogenolysis, playing a central role in interprandial blood-glucose homeostasis. Two alternatively spliced isoforms exist (isoform 2/vG6PT includes an extra exon-7 segment); both are active G6P transporters. Loss-of-function variants cause glycogen storage disease type Ib (von Gierke type Ib), combining the GSD Ia-like metabolic phenotype (fasting hypoglycemia, hepatomegaly, lactic acidemia, hyperlipidemia) with neutropenia, neutrophil dysfunction and inflammatory-bowel-disease-like features, reflecting the transporter's role in both the hepatic G6PC1 and the neutrophil G6PC3 systems. A distinct dominant variant (p.Arg423*) that removes the C-terminal ER-retention signal mislocalizes the transporter to the Golgi and causes a congenital disorder of glycosylation (CDG-IIw) with liver dysfunction and coagulopathy.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005789 endoplasmic reticulum membrane
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) annotation placing the active SLC37A4 protein in the ER membrane. This is the well-established site of action of the G6P/Pi antiporter and is directly supported by experimental localization data.
Reason: The ER membrane is the correct, experimentally confirmed compartment for this transporter (see the IDA/EXP annotations below), and the phylogenetic inference is consistent with orthologs. Retain as a core localization.
Supporting Evidence:
PMID:21949678
The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
GO:0061513 glucose 6-phosphate:phosphate antiporter activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) annotation for the defining molecular function: glucose 6-phosphate:phosphate antiporter activity. This is the correct, most informative MF term and is heavily supported by experimental evidence.
Reason: This is the core molecular function of SLC37A4/G6PT, confirmed biochemically in reconstituted proteoliposomes as a dual G6P/Pi antiporter. The IBA is at the right level of specificity.
Supporting Evidence:
PMID:18337460
our results suggest that G6PT has a dual role as a G6P and a P(i)
PMID:21949678
The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
GO:0015760 glucose-6-phosphate transport
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) annotation for the biological process of glucose-6-phosphate transport, the direct process carried out by this antiporter.
Reason: G6P transport across the ER membrane is the direct, core biological process of SLC37A4, supported by multiple experimental (IMP/IDA) annotations. Retain as core.
Supporting Evidence:
PMID:21949678
The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
GO:0035435 phosphate ion transmembrane transport
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic (IBA) annotation for phosphate ion transmembrane transport. Because SLC37A4 is an antiporter, inorganic phosphate is the counter-substrate moved in the opposite direction to G6P, so phosphate transport is a genuine part of its activity.
Reason: Phosphate transport is real but is the counter-transport leg of the G6P:Pi antiport rather than the physiologically salient function; the G6P-directed terms capture the core role. Keep as a non-core aspect.
Supporting Evidence:
PMID:18337460
our results suggest that G6PT has a dual role as a G6P and a P(i)
GO:0005789 endoplasmic reticulum membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Electronic annotation (UniProt Subcellular Location mapping) placing SLC37A4 in the ER membrane. Correct and consistent with experimental localization.
Reason: The UniProt SubCell mapping (SL-0097, ER membrane) is accurate and matches the experimentally determined localization. Retain.
Supporting Evidence:
PMID:32884905
The wildtype protein resides in the ER of HepG2 tetoff cells
GO:0016020 membrane
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Electronic (InterPro2GO) annotation to the generic term "membrane". SLC37A4 is indeed a membrane protein, but this term is far less specific than the experimentally supported ER membrane localization.
Reason: "membrane" is trivially true for a multi-pass transporter but uninformative given that the specific compartment (ER membrane) is well established. Over-annotation.
Supporting Evidence:
PMID:32884905
The wildtype protein resides in the ER of HepG2 tetoff cells
GO:0022857 transmembrane transporter activity
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Electronic (InterPro2GO) annotation to the very general MF "transmembrane transporter activity". Correct in essence but much broader than the specific G6P:Pi antiporter activity that is experimentally established.
Reason: The specific antiporter activity (GO:0061513) and the G6P transmembrane transporter activity (GO:0015152) are the informative MF terms; the generic parent adds no information. Mark as over-annotated rather than removing an InterPro-based root term.
Supporting Evidence:
PMID:18337460
our results suggest that G6PT has a dual role as a G6P and a P(i)
GO:0055085 transmembrane transport
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: Electronic (InterPro2GO) annotation to the general BP "transmembrane transport". True but general relative to the specific glucose-6-phosphate transport process.
Reason: Correct high-level process; the specific G6P transport (GO:0015760) is the core term. Keep as a valid but non-core parent.
Supporting Evidence:
PMID:21949678
The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: IPI annotation to the uninformative "protein binding" term, from a high-throughput yeast-two-hybrid interactome map (HuRI) reporting an interaction with BIK (UniProtKB:Q13323). This is a bare binding annotation with no functional context.
Reason: Per curation guidelines, bare "protein binding" is not informative about molecular function. The single high-throughput binary interaction (with BIK) has no established functional consequence for the G6P antiporter and should not be treated as a core function. Retained but flagged (not removed, per policy on IPI binding annotations).
Supporting Evidence:
PMID:32296183
HuRI is a systematic proteome-wide reference that links genomic
GO:0006094 gluconeogenesis
TAS
Reactome:R-HSA-70263
KEEP AS NON CORE
Summary: TAS (Reactome) annotation to gluconeogenesis. SLC37A4 supplies G6P to the ER-luminal glucose-6-phosphatase, carrying out the terminal, glucose-releasing step common to gluconeogenesis and glycogenolysis, so participation in gluconeogenesis is correct.
Reason: SLC37A4 contributes to gluconeogenesis by delivering G6P for the final hydrolysis step, but its molecular activity is transport, not a gluconeogenic enzymatic step. Retain as a valid contributory (non-core) process annotation.
Supporting Evidence:
PMID:21949678
Together, the G6PT/G6Pase-α complex maintains interprandial glucose homeostasis
GO:0061513 glucose 6-phosphate:phosphate antiporter activity
EXP
PMID:18337460
The glucose-6-phosphate transporter is a phosphate-linked an...
ACCEPT
Summary: Experimental annotation for the G6P:Pi antiporter activity, based on reconstituted proteoliposome transport assays demonstrating the dual G6P/Pi antiport function.
Reason: Direct biochemical demonstration of the defining molecular function in proteoliposomes; a null mutant (p.R28H) abolished transport. Core function.
Supporting Evidence:
PMID:18337460
our results suggest that G6PT has a dual role as a G6P and a P(i)
GO:0061513 glucose 6-phosphate:phosphate antiporter activity
TAS
Reactome:R-HSA-3229118
ACCEPT
Summary: TAS (Reactome) annotation for the G6P:Pi antiporter activity across the ER membrane. Consistent with the experimental evidence.
Reason: Correct, well-supported core molecular function; duplicate of the EXP/IDA/IBA antiporter annotations with an authoritative source.
Supporting Evidence:
PMID:18337460
our results suggest that G6PT has a dual role as a G6P and a P(i)
GO:0005789 endoplasmic reticulum membrane
EXP
PMID:32884905
SLC37A4-CDG: Mislocalization of the glucose-6-phosphate tran...
ACCEPT
Summary: Experimental localization to the ER membrane; wild-type SLC37A4 resides in the ER (contrasted with the Golgi-mislocalizing R423* CDG variant).
Reason: Direct experimental support for ER membrane localization of the wild-type protein. Core localization.
Supporting Evidence:
PMID:32884905
The wildtype protein resides in the ER of HepG2 tetoff cells
GO:0061513 glucose 6-phosphate:phosphate antiporter activity
EXP
PMID:10026167
Inactivation of the glucose 6-phosphate transporter causes g...
ACCEPT
Summary: Experimental annotation for the antiporter activity based on functional characterization of the recombinant G6P transporter and the demonstration that GSD-1b mutations disrupt G6P transport.
Reason: Foundational functional characterization establishing the molecular activity of the transporter and its loss in disease mutants. Core function.
Supporting Evidence:
PMID:10026167
mutations uncovered in GSD-1b patients disrupt G6P
GO:0061513 glucose 6-phosphate:phosphate antiporter activity
EXP
PMID:33964207
A mutation in SLC37A4 causes a dominantly inherited congenit...
ACCEPT
Summary: Experimental annotation for the antiporter activity; SLC37A4 is required for transporting glucose-6-phosphate into the ER, where it is hydrolyzed to glucose and phosphate.
Reason: Supports the transport/antiport function of the ER-localized transporter. Core molecular function.
Supporting Evidence:
PMID:33964207
required for transporting glucose-6-phosphate (Glc-6P) into the ER
GO:0005789 endoplasmic reticulum membrane
IDA
PMID:33964207
A mutation in SLC37A4 causes a dominantly inherited congenit...
ACCEPT
Summary: IDA localization of SLC37A4 to the ER membrane (wild-type protein), consistent with other experimental localization data.
Reason: Directly observed ER localization of the wild-type transporter. Core localization.
Supporting Evidence:
PMID:33964207
SLC37A4 encodes an endoplasmic reticulum (ER)-localized multitransmembrane
GO:0015760 glucose-6-phosphate transport
IMP
PMID:10026167
Inactivation of the glucose 6-phosphate transporter causes g...
ACCEPT
Summary: IMP annotation for glucose-6-phosphate transport; GSD-1b mutations were shown to disrupt G6P transport, implicating SLC37A4 in this process.
Reason: Mutational evidence directly links SLC37A4 to the G6P transport process. Core.
Supporting Evidence:
PMID:10026167
mutations uncovered in GSD-1b patients disrupt G6P
GO:0015760 glucose-6-phosphate transport
IMP
PMID:33964207
A mutation in SLC37A4 causes a dominantly inherited congenit...
ACCEPT
Summary: IMP annotation for glucose-6-phosphate transport, from characterization of the SLC37A4 R423* variant and the transporter's role in importing G6P into the ER.
Reason: Supports the core G6P transport process of SLC37A4. Core.
Supporting Evidence:
PMID:33964207
required for transporting glucose-6-phosphate (Glc-6P) into the ER
GO:0061513 glucose 6-phosphate:phosphate antiporter activity
IDA
PMID:18337460
The glucose-6-phosphate transporter is a phosphate-linked an...
ACCEPT
Summary: IDA annotation for the G6P:Pi antiporter activity from proteoliposome transport assays (MGI-assigned; same primary paper as the EXP annotation).
Reason: Direct assay of the dual G6P/Pi antiport function. Core molecular function.
Supporting Evidence:
PMID:18337460
our results suggest that G6PT has a dual role as a G6P and a P(i)
GO:0015760 glucose-6-phosphate transport
NAS
PMID:9428641
Sequence of a putative glucose 6-phosphate translocase, muta...
ACCEPT
Summary: NAS annotation for glucose-6-phosphate transport based on the original cDNA cloning, identifying the protein as the glucose-6-phosphate translocase functionally associated with glucose-6-phosphatase.
Reason: The founding paper assigns the G6P translocase role; concordant with later experimental evidence for the core transport process.
Supporting Evidence:
PMID:9428641
most likely the glucose 6-phosphate translocase that is
GO:0005789 endoplasmic reticulum membrane
IDA
PMID:21949678
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphat...
ACCEPT
Summary: IDA localization to the ER membrane, based on immunofluorescence co-localization with the ER marker calreticulin.
Reason: Direct experimental support for ER membrane localization. Core localization.
Supporting Evidence:
PMID:21949678
The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
GO:0015760 glucose-6-phosphate transport
IDA
PMID:21949678
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphat...
ACCEPT
Summary: IDA annotation for glucose-6-phosphate transport from reconstituted proteoliposome G6P uptake assays for G6PT/SLC37A4.
Reason: Direct functional demonstration of G6P transport; core process.
Supporting Evidence:
PMID:21949678
The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
GO:0035435 phosphate ion transmembrane transport
IDA
PMID:21949678
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphat...
KEEP AS NON CORE
Summary: IDA annotation for phosphate ion transmembrane transport, from proteoliposome assays showing Pi uptake as the counter-substrate of the G6P:Pi antiport.
Reason: Pi transport is directly measured but represents the counter-transport leg of the antiporter; the G6P-directed function is the physiologically core role. Keep as non-core.
Supporting Evidence:
PMID:18337460
our results suggest that G6PT has a dual role as a G6P and a P(i)
GO:0061513 glucose 6-phosphate:phosphate antiporter activity
IDA
PMID:21949678
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphat...
ACCEPT
Summary: IDA annotation for the G6P:Pi antiporter activity from reconstituted proteoliposomes; G6PT is the physiological ER G6P antiporter that couples to glucose-6-phosphatase-α.
Reason: Direct biochemical demonstration of the defining antiporter activity, including CHA sensitivity and coupling to G6Pase-α that distinguishes G6PT from other SLC37 members. Core function.
Supporting Evidence:
PMID:21949678
Taken together these findings suggest that only SCL37A4 contributes to interprandial blood glucose homeostasis
GO:0016020 membrane
HDA
PMID:19946888
Defining the membrane proteome of NK cells.
MARK AS OVER ANNOTATED
Summary: High-throughput direct assay (membrane proteomics of an NK-like cell line) detecting SLC37A4 in the membrane fraction. Confirms membrane association but is unspecific.
Reason: A proteomics hit to the generic "membrane" term adds nothing beyond the specific, experimentally established ER membrane localization. Over-annotation (kept, not removed).
Supporting Evidence:
PMID:19946888
approximately 40% of the identified proteins were predicted as plausible membrane proteins
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-3229118
ACCEPT
Summary: TAS (Reactome) annotation for ER membrane localization, consistent with all experimental localization data.
Reason: Correct core localization from an authoritative pathway source.
Supporting Evidence:
PMID:21949678
The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-198513
ACCEPT
Summary: TAS (Reactome) annotation for ER membrane localization (G6P/Pi exchange reaction across the ER membrane).
Reason: Correct core localization; concordant with experimental data.
Supporting Evidence:
PMID:21949678
The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
GO:0005783 endoplasmic reticulum
NAS
PMID:212064
A new variant of glycogen storage disease type I probably du...
KEEP AS NON CORE
Summary: NAS annotation to the general "endoplasmic reticulum" term, from an early description of a GSD type I variant attributed to a defect in the G6P transport system.
Reason: Correct compartment but less specific than the well-supported ER membrane term; the transporter is an integral membrane protein, so ER membrane is preferred. Keep as non-core / less specific.
Supporting Evidence:
PMID:212064
A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system
GO:0006006 glucose metabolic process
NAS
PMID:9428641
Sequence of a putative glucose 6-phosphate translocase, muta...
KEEP AS NON CORE
Summary: NAS annotation to the broad "glucose metabolic process" term. SLC37A4 participates in glucose metabolism by supplying G6P for hydrolysis to glucose, but this is a very general process term.
Reason: True but broad; the specific G6P transport and glucose homeostasis terms capture the informative process roles. Keep as non-core parent.
Supporting Evidence:
PMID:9428641
most likely the glucose 6-phosphate translocase that is
GO:0015152 glucose-6-phosphate transmembrane transporter activity
IMP
PMID:12560945
The signature motif in human glucose-6-phosphate transporter...
ACCEPT
Summary: IMP annotation for glucose-6-phosphate transmembrane transporter activity; mutations in the transporter's signature motif abolish microsomal G6P uptake, showing the motif is required for G6P transport.
Reason: Mutational evidence directly supports G6P transmembrane transporter activity. This is a correct, informative MF term (a close, slightly less specific companion to the G6P:Pi antiporter term). Core function.
Supporting Evidence:
PMID:12560945
the signature motif is a
GO:0015152 glucose-6-phosphate transmembrane transporter activity
IDA
O43826-2
PMID:11140953
Human variant glucose-6-phosphate transporter is active in m...
ACCEPT
Summary: IDA annotation (on isoform 2, the variant vG6PT) for glucose-6-phosphate transmembrane transporter activity; vG6PT is active in microsomal G6P transport. The isoform field records what was assayed, not an isoform-unique function.
Reason: Direct demonstration that isoform 2 also transports G6P confirms the MF and shows the exon-7 luminal-loop insertion does not impair transport. Core function (isoform 2).
Supporting Evidence:
PMID:11140953
vG6PT is also active in microsomal G6P
GO:0015760 glucose-6-phosphate transport
IMP
PMID:12560945
The signature motif in human glucose-6-phosphate transporter...
ACCEPT
Summary: IMP annotation for glucose-6-phosphate transport; signature-motif mutants lack microsomal G6P uptake, implicating SLC37A4 in the transport process.
Reason: Mutational evidence supports the core G6P transport process. Core.
Supporting Evidence:
PMID:12560945
required for microsomal glucose-6-phosphate transport
GO:0015760 glucose-6-phosphate transport
IDA
O43826-2
PMID:11140953
Human variant glucose-6-phosphate transporter is active in m...
ACCEPT
Summary: IDA annotation (on isoform 2/vG6PT) for glucose-6-phosphate transport; the variant isoform is active in microsomal G6P transport.
Reason: Direct evidence that isoform 2 carries out G6P transport. Core process (isoform 2); not a unique isoform function.
Supporting Evidence:
PMID:11140953
vG6PT is also active in microsomal G6P
GO:0016020 membrane
NAS
PMID:9428641
Sequence of a putative glucose 6-phosphate translocase, muta...
MARK AS OVER ANNOTATED
Summary: NAS annotation to the generic "membrane" term based on the original cloning of a transmembrane protein with a C-terminal ER retention motif.
Reason: The generic membrane term is subsumed by the specific ER membrane localization (the same paper notes the ER retention motif). Over-annotation.
Supporting Evidence:
PMID:9428641
presents at its carboxy terminus the consensus motif for retention in the
GO:0042593 glucose homeostasis
IDA
O43826-2
PMID:11140953
Human variant glucose-6-phosphate transporter is active in m...
ACCEPT
Summary: IDA annotation (on isoform 2/vG6PT) for glucose homeostasis; the G6P transporter works together with glucose-6-phosphatase to maintain glucose homeostasis.
Reason: SLC37A4/G6PT has a central, experimentally supported role in interprandial blood-glucose homeostasis by supplying G6P for hydrolysis to glucose. A core physiological process for this gene.
Supporting Evidence:
PMID:11140953
which works together with glucose-6-phosphatase to maintain glucose homeostasis

Core Functions

Glucose-6-phosphate:inorganic-phosphate antiport across the endoplasmic reticulum membrane, moving cytosolic glucose-6-phosphate into the ER lumen in exchange for luminal inorganic phosphate.

Supporting Evidence:
  • PMID:18337460
    our results suggest that G6PT has a dual role as a G6P and a P(i)
  • PMID:21949678
    The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi

Glucose-6-phosphate transmembrane transport into the ER, delivering G6P substrate to the luminal glucose-6-phosphatase catalytic subunits and thereby supporting interprandial blood-glucose homeostasis (terminal step of gluconeogenesis and glycogenolysis).

Supporting Evidence:
  • PMID:12560945
    required for microsomal glucose-6-phosphate transport
  • PMID:21949678
    Together, the G6PT/G6Pase-α complex maintains interprandial glucose homeostasis

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.
Human variant glucose-6-phosphate transporter is active in microsomal transport.
The signature motif in human glucose-6-phosphate transporter is essential for microsomal transport of glucose-6-phosphate.
The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
Defining the membrane proteome of NK cells.
A new variant of glycogen storage disease type I probably due to a defect in the glucose-6-phosphate transport system.
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
A reference map of the human binary protein interactome.
SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the Golgi causes a new congenital disorder of glycosylation.
A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.
Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib.
Reactome:R-HSA-198513
SLC7A4 exchanges G6P for Pi across the ER membrane
Reactome:R-HSA-3229118
Defective SLC37A4 does not exchange G6P and Pi across the ER membrane
Reactome:R-HSA-70263
Gluconeogenesis

Suggested Questions for Experts

Q: Beyond the hepatic G6PC1 axis, how does G6PT (with the ubiquitous G6PC3) support neutrophil function, and what molecular mechanism links the transporter defect to neutropenia and neutrophil dysfunction in GSD Ib?

Q: Do the two SLC37A4 isoforms (canonical vs vG6PT) differ in tissue-specific regulation or kinetics despite both being active G6P transporters?

Suggested Experiments

Experiment: Cryo-EM/functional dissection of the G6P:Pi antiport cycle to define the stoichiometry and the residues gating G6P entry versus Pi counter-transport (building on the 2025 structures), and test how GSD Ib missense variants perturb each half-cycle.

Experiment: Cell-based assays coupling G6PT with G6PC1 versus G6PC3 to quantify how the transporter partitions between the hepatic gluconeogenic and the neutrophil (energy/1,5-anhydroglucitol-6-phosphate detox) systems.

📚 Additional Documentation

Notes

(SLC37A4-notes.md)

SLC37A4 (G6PT / G6PT1) — curation notes

UniProtKB: O43826 (G6PT1_HUMAN). Gene: SLC37A4 (HGNC:4061). Synonyms: G6PT, G6PT1,
glucose-6-phosphate translocase, TRG-19. 429 aa, multi-pass ER membrane protein.

Deep research: falcon provider is out of credits (HTTP 402); no
-deep-research-falcon.md generated. Review grounded in the UniProt record, seeded
GOA, and cached publications/PMID_*.md.

Core biology (verified)

SLC37A4/G6PT is the glucose-6-phosphate:inorganic-phosphate antiporter of the ER
membrane
. It moves cytosolic glucose-6-phosphate (G6P) into the ER lumen in exchange
for luminal inorganic phosphate (Pi), delivering the G6P substrate to the luminal
active site of the glucose-6-phosphatase catalytic subunits (G6PC1 in liver/kidney/
intestine; G6PC3 ubiquitously incl. neutrophils). Belongs to the MFS,
organophosphate:Pi antiporter (OPA) family (TC 2.A.1.4).

  • Dual G6P/Pi antiporter, reconstituted proteoliposomes: PMID:18337460.
  • Physiological ER G6P transporter, couples to G6Pase-α; primary function is to
    translocate G6P from cytoplasm into ER lumen for hydrolysis: PMID:21949678; PMID:21949678.
  • ER-localized multitransmembrane protein required for transporting G6P into ER:
    PMID:33964207.
  • Import of G6P into ER done by G6PT1, spans membrane; ER retrieval signal (KKXX):
    PMID:32884905.
  • Original cloning; ER retention motif; liver/kidney expression; associated with
    glucose-6-phosphatase: PMID:9428641, PMID:9428641.
  • GSD1b caused by inactivation of G6P transport; contributes to neutropenia:
    PMID:10026167.
  • Signature motif required for microsomal G6P transport:
    PMID:12560945.

Isoform 2 (O43826-2, variant vG6PT)

Isoform 2 (VSP_006171; includes a 66-bp exon-7 giving +22 aa in luminal loop 4) is also
an active microsomal G6P transporter and functions in glucose homeostasis:
PMID:11140953,
PMID:11140953.
Note: isoform-specific annotations in GOA (GO:0015152, GO:0015760, GO:0042593 on
O43826-2) reflect what was tested (the variant), not a function unique to isoform 2 —
both isoforms transport G6P.

Localization

ER membrane, multi-pass, 10–12 TM (UniProt: 12 TM helices resolved by cryo-EM; older
literature says 10). ER retrieval signal at C-terminus. Structures (2025 cryo-EM,
PMID:41136424, PMID:41225049) show monomer, pseudo-two-fold N/C domains, central G6P
pocket; inhibited by chlorogenic acid & vanadate. (These structural PMIDs are not in
GOA and not cached; not used for supporting_text.)
- ER membrane loc, WT resides in ER: PMID:32884905.

Disease

  • GSD Ib (MIM:232220): metabolic phenotype (fasting hypoglycemia, hepatomegaly, lactic
    acidemia, hyperlipidemia, hyperuricemia) PLUS neutropenia, neutrophil dysfunction,
    IBD-like features. GSD Ic/Id historically ascribed to a separate Pi transporter are
    now known to be the same G6PT gene (PMID:18337460).
  • CDG2W (MIM:619525): dominant, R423* removes ER retention signal → mislocalization to
    Golgi → congenital disorder of glycosylation with liver dysfunction & coagulopathy
    (PMID:32884905, PMID:33964207).

Annotation review decisions (summary)

  • MF GO:0061513 (G6P:Pi antiporter) — the definitive molecular function. Multiple EXP/
    IDA/IBA/TAS. ACCEPT (core). Duplicates all accepted.
  • MF GO:0015152 (glucose-6-phosphate transmembrane transporter activity) — correct,
    slightly less informative than the antiporter term but valid. ACCEPT (core).
  • MF GO:0022857 (transmembrane transporter activity, IEA/InterPro) — correct but far too
    general given the specific antiporter term. MARK_AS_OVER_ANNOTATED.
  • MF GO:0005515 (protein binding, IPI, BIK interaction, PMID:32296183/HuRI) — bare
    protein binding, uninformative; per policy MARK_AS_OVER_ANNOTATED (not REMOVE).
  • BP GO:0015760 (glucose-6-phosphate transport) — direct core process. ACCEPT.
  • BP GO:0035435 (phosphate ion transmembrane transport) — correct (the antiport moves Pi
    the other way). ACCEPT / KEEP_AS_NON_CORE (the Pi leg is the counter-substrate).
  • BP GO:0006094 (gluconeogenesis, TAS Reactome) & GO:0006006 (glucose metabolic process,
    NAS) — SLC37A4 enables the terminal step of both gluconeogenesis and glycogenolysis by
    supplying G6P to G6Pase; these are legitimate but broad process roles.
    KEEP_AS_NON_CORE (contributory, not the molecular function).
  • BP GO:0042593 (glucose homeostasis, IDA on isoform 2) — central physiological role.
    ACCEPT / core-adjacent.
  • BP GO:0055085 (transmembrane transport, IEA) — correct but general. KEEP_AS_NON_CORE.
  • CC GO:0005789 (ER membrane) — correct, well supported (IDA, EXP, IBA, IEA, TAS). ACCEPT.
  • CC GO:0005783 (ER, NAS) — correct but less specific than ER membrane. KEEP_AS_NON_CORE.
  • CC GO:0016020 (membrane, IEA/HDA/NAS) — trivially true, far less specific than ER
    membrane. MARK_AS_OVER_ANNOTATED.

📄 View Raw YAML

id: O43826
gene_symbol: SLC37A4
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  SLC37A4 (glucose-6-phosphate exchanger; G6PT/G6PT1) is a multi-pass endoplasmic
  reticulum membrane transporter of the SLC37 sugar-phosphate/phosphate exchanger
  family (major facilitator superfamily, organophosphate:Pi antiporter clade). It is
  the glucose-6-phosphate:inorganic-phosphate antiporter that translocates cytosolic
  glucose-6-phosphate (G6P) into the ER lumen in exchange for luminal inorganic
  phosphate. By importing G6P into the ER, it delivers the substrate to the luminal
  active site of the glucose-6-phosphatase catalytic subunits (G6PC1 in liver, kidney
  and intestine; G6PC3 ubiquitously, including neutrophils), and thereby carries out
  the terminal, glucose-releasing step shared by gluconeogenesis and glycogenolysis,
  playing a central role in interprandial blood-glucose homeostasis. Two alternatively
  spliced isoforms exist (isoform 2/vG6PT includes an extra exon-7 segment); both are
  active G6P transporters. Loss-of-function variants cause glycogen storage disease
  type Ib (von Gierke type Ib), combining the GSD Ia-like metabolic phenotype (fasting
  hypoglycemia, hepatomegaly, lactic acidemia, hyperlipidemia) with neutropenia,
  neutrophil dysfunction and inflammatory-bowel-disease-like features, reflecting the
  transporter's role in both the hepatic G6PC1 and the neutrophil G6PC3 systems. A
  distinct dominant variant (p.Arg423*) that removes the C-terminal ER-retention signal
  mislocalizes the transporter to the Golgi and causes a congenital disorder of
  glycosylation (CDG-IIw) with liver dysfunction and coagulopathy.
alternative_products:
- name: '1'
  id: O43826-1
- name: '2'
  id: O43826-2
  sequence_note: VSP_006171
existing_annotations:
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Phylogenetic (IBA) annotation placing the active SLC37A4 protein in the ER
      membrane. This is the well-established site of action of the G6P/Pi antiporter and
      is directly supported by experimental localization data.
    action: ACCEPT
    reason: >-
      The ER membrane is the correct, experimentally confirmed compartment for this
      transporter (see the IDA/EXP annotations below), and the phylogenetic inference is
      consistent with orthologs. Retain as a core localization.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
- term:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetic (IBA) annotation for the defining molecular function: glucose
      6-phosphate:phosphate antiporter activity. This is the correct, most informative
      MF term and is heavily supported by experimental evidence.
    action: ACCEPT
    reason: >-
      This is the core molecular function of SLC37A4/G6PT, confirmed biochemically in
      reconstituted proteoliposomes as a dual G6P/Pi antiporter. The IBA is at the right
      level of specificity.
    supported_by:
    - reference_id: PMID:18337460
      supporting_text: >-
        our results suggest that G6PT has a dual role as a G6P and a P(i)
    - reference_id: PMID:21949678
      supporting_text: >-
        The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
- term:
    id: GO:0015760
    label: glucose-6-phosphate transport
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic (IBA) annotation for the biological process of glucose-6-phosphate
      transport, the direct process carried out by this antiporter.
    action: ACCEPT
    reason: >-
      G6P transport across the ER membrane is the direct, core biological process of
      SLC37A4, supported by multiple experimental (IMP/IDA) annotations. Retain as core.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
- term:
    id: GO:0035435
    label: phosphate ion transmembrane transport
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic (IBA) annotation for phosphate ion transmembrane transport. Because
      SLC37A4 is an antiporter, inorganic phosphate is the counter-substrate moved in the
      opposite direction to G6P, so phosphate transport is a genuine part of its activity.
    action: KEEP_AS_NON_CORE
    reason: >-
      Phosphate transport is real but is the counter-transport leg of the G6P:Pi
      antiport rather than the physiologically salient function; the G6P-directed terms
      capture the core role. Keep as a non-core aspect.
    supported_by:
    - reference_id: PMID:18337460
      supporting_text: >-
        our results suggest that G6PT has a dual role as a G6P and a P(i)
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Electronic annotation (UniProt Subcellular Location mapping) placing SLC37A4 in the
      ER membrane. Correct and consistent with experimental localization.
    action: ACCEPT
    reason: >-
      The UniProt SubCell mapping (SL-0097, ER membrane) is accurate and matches the
      experimentally determined localization. Retain.
    supported_by:
    - reference_id: PMID:32884905
      supporting_text: >-
        The wildtype protein resides in the ER of HepG2 tetoff cells
- term:
    id: GO:0016020
    label: membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: located_in
  review:
    summary: >-
      Electronic (InterPro2GO) annotation to the generic term "membrane". SLC37A4 is
      indeed a membrane protein, but this term is far less specific than the
      experimentally supported ER membrane localization.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      "membrane" is trivially true for a multi-pass transporter but uninformative given
      that the specific compartment (ER membrane) is well established. Over-annotation.
    supported_by:
    - reference_id: PMID:32884905
      supporting_text: >-
        The wildtype protein resides in the ER of HepG2 tetoff cells
- term:
    id: GO:0022857
    label: transmembrane transporter activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      Electronic (InterPro2GO) annotation to the very general MF "transmembrane
      transporter activity". Correct in essence but much broader than the specific G6P:Pi
      antiporter activity that is experimentally established.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The specific antiporter activity (GO:0061513) and the G6P transmembrane transporter
      activity (GO:0015152) are the informative MF terms; the generic parent adds no
      information. Mark as over-annotated rather than removing an InterPro-based root term.
    supported_by:
    - reference_id: PMID:18337460
      supporting_text: >-
        our results suggest that G6PT has a dual role as a G6P and a P(i)
- term:
    id: GO:0055085
    label: transmembrane transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      Electronic (InterPro2GO) annotation to the general BP "transmembrane transport".
      True but general relative to the specific glucose-6-phosphate transport process.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct high-level process; the specific G6P transport (GO:0015760) is the core
      term. Keep as a valid but non-core parent.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: >-
      IPI annotation to the uninformative "protein binding" term, from a high-throughput
      yeast-two-hybrid interactome map (HuRI) reporting an interaction with BIK
      (UniProtKB:Q13323). This is a bare binding annotation with no functional context.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Per curation guidelines, bare "protein binding" is not informative about molecular
      function. The single high-throughput binary interaction (with BIK) has no
      established functional consequence for the G6P antiporter and should not be treated
      as a core function. Retained but flagged (not removed, per policy on IPI binding
      annotations).
    supported_by:
    - reference_id: PMID:32296183
      supporting_text: >-
        HuRI is a systematic proteome-wide reference that links genomic
- term:
    id: GO:0006094
    label: gluconeogenesis
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70263
  qualifier: involved_in
  review:
    summary: >-
      TAS (Reactome) annotation to gluconeogenesis. SLC37A4 supplies G6P to the ER-luminal
      glucose-6-phosphatase, carrying out the terminal, glucose-releasing step common to
      gluconeogenesis and glycogenolysis, so participation in gluconeogenesis is correct.
    action: KEEP_AS_NON_CORE
    reason: >-
      SLC37A4 contributes to gluconeogenesis by delivering G6P for the final hydrolysis
      step, but its molecular activity is transport, not a gluconeogenic enzymatic step.
      Retain as a valid contributory (non-core) process annotation.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        Together, the G6PT/G6Pase-α complex maintains interprandial glucose homeostasis
- term:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  evidence_type: EXP
  original_reference_id: PMID:18337460
  qualifier: enables
  review:
    summary: >-
      Experimental annotation for the G6P:Pi antiporter activity, based on reconstituted
      proteoliposome transport assays demonstrating the dual G6P/Pi antiport function.
    action: ACCEPT
    reason: >-
      Direct biochemical demonstration of the defining molecular function in
      proteoliposomes; a null mutant (p.R28H) abolished transport. Core function.
    supported_by:
    - reference_id: PMID:18337460
      supporting_text: >-
        our results suggest that G6PT has a dual role as a G6P and a P(i)
- term:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3229118
  qualifier: enables
  review:
    summary: >-
      TAS (Reactome) annotation for the G6P:Pi antiporter activity across the ER membrane.
      Consistent with the experimental evidence.
    action: ACCEPT
    reason: >-
      Correct, well-supported core molecular function; duplicate of the EXP/IDA/IBA
      antiporter annotations with an authoritative source.
    supported_by:
    - reference_id: PMID:18337460
      supporting_text: >-
        our results suggest that G6PT has a dual role as a G6P and a P(i)
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: EXP
  original_reference_id: PMID:32884905
  qualifier: located_in
  review:
    summary: >-
      Experimental localization to the ER membrane; wild-type SLC37A4 resides in the ER
      (contrasted with the Golgi-mislocalizing R423* CDG variant).
    action: ACCEPT
    reason: >-
      Direct experimental support for ER membrane localization of the wild-type protein.
      Core localization.
    supported_by:
    - reference_id: PMID:32884905
      supporting_text: >-
        The wildtype protein resides in the ER of HepG2 tetoff cells
- term:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  evidence_type: EXP
  original_reference_id: PMID:10026167
  qualifier: enables
  review:
    summary: >-
      Experimental annotation for the antiporter activity based on functional
      characterization of the recombinant G6P transporter and the demonstration that
      GSD-1b mutations disrupt G6P transport.
    action: ACCEPT
    reason: >-
      Foundational functional characterization establishing the molecular activity of the
      transporter and its loss in disease mutants. Core function.
    supported_by:
    - reference_id: PMID:10026167
      supporting_text: >-
        mutations uncovered in GSD-1b patients disrupt G6P
- term:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  evidence_type: EXP
  original_reference_id: PMID:33964207
  qualifier: enables
  review:
    summary: >-
      Experimental annotation for the antiporter activity; SLC37A4 is required for
      transporting glucose-6-phosphate into the ER, where it is hydrolyzed to glucose and
      phosphate.
    action: ACCEPT
    reason: >-
      Supports the transport/antiport function of the ER-localized transporter. Core
      molecular function.
    supported_by:
    - reference_id: PMID:33964207
      supporting_text: >-
        required for transporting glucose-6-phosphate (Glc-6P) into the ER
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IDA
  original_reference_id: PMID:33964207
  qualifier: located_in
  review:
    summary: >-
      IDA localization of SLC37A4 to the ER membrane (wild-type protein), consistent with
      other experimental localization data.
    action: ACCEPT
    reason: >-
      Directly observed ER localization of the wild-type transporter. Core localization.
    supported_by:
    - reference_id: PMID:33964207
      supporting_text: >-
        SLC37A4 encodes an endoplasmic reticulum (ER)-localized multitransmembrane
- term:
    id: GO:0015760
    label: glucose-6-phosphate transport
  evidence_type: IMP
  original_reference_id: PMID:10026167
  qualifier: involved_in
  review:
    summary: >-
      IMP annotation for glucose-6-phosphate transport; GSD-1b mutations were shown to
      disrupt G6P transport, implicating SLC37A4 in this process.
    action: ACCEPT
    reason: >-
      Mutational evidence directly links SLC37A4 to the G6P transport process. Core.
    supported_by:
    - reference_id: PMID:10026167
      supporting_text: >-
        mutations uncovered in GSD-1b patients disrupt G6P
- term:
    id: GO:0015760
    label: glucose-6-phosphate transport
  evidence_type: IMP
  original_reference_id: PMID:33964207
  qualifier: involved_in
  review:
    summary: >-
      IMP annotation for glucose-6-phosphate transport, from characterization of the
      SLC37A4 R423* variant and the transporter's role in importing G6P into the ER.
    action: ACCEPT
    reason: >-
      Supports the core G6P transport process of SLC37A4. Core.
    supported_by:
    - reference_id: PMID:33964207
      supporting_text: >-
        required for transporting glucose-6-phosphate (Glc-6P) into the ER
- term:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  evidence_type: IDA
  original_reference_id: PMID:18337460
  qualifier: enables
  review:
    summary: >-
      IDA annotation for the G6P:Pi antiporter activity from proteoliposome transport
      assays (MGI-assigned; same primary paper as the EXP annotation).
    action: ACCEPT
    reason: >-
      Direct assay of the dual G6P/Pi antiport function. Core molecular function.
    supported_by:
    - reference_id: PMID:18337460
      supporting_text: >-
        our results suggest that G6PT has a dual role as a G6P and a P(i)
- term:
    id: GO:0015760
    label: glucose-6-phosphate transport
  evidence_type: NAS
  original_reference_id: PMID:9428641
  qualifier: involved_in
  review:
    summary: >-
      NAS annotation for glucose-6-phosphate transport based on the original cDNA cloning,
      identifying the protein as the glucose-6-phosphate translocase functionally
      associated with glucose-6-phosphatase.
    action: ACCEPT
    reason: >-
      The founding paper assigns the G6P translocase role; concordant with later
      experimental evidence for the core transport process.
    supported_by:
    - reference_id: PMID:9428641
      supporting_text: >-
        most likely the glucose 6-phosphate translocase that is
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IDA
  original_reference_id: PMID:21949678
  qualifier: located_in
  review:
    summary: >-
      IDA localization to the ER membrane, based on immunofluorescence co-localization
      with the ER marker calreticulin.
    action: ACCEPT
    reason: >-
      Direct experimental support for ER membrane localization. Core localization.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
- term:
    id: GO:0015760
    label: glucose-6-phosphate transport
  evidence_type: IDA
  original_reference_id: PMID:21949678
  qualifier: involved_in
  review:
    summary: >-
      IDA annotation for glucose-6-phosphate transport from reconstituted proteoliposome
      G6P uptake assays for G6PT/SLC37A4.
    action: ACCEPT
    reason: >-
      Direct functional demonstration of G6P transport; core process.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
- term:
    id: GO:0035435
    label: phosphate ion transmembrane transport
  evidence_type: IDA
  original_reference_id: PMID:21949678
  qualifier: involved_in
  review:
    summary: >-
      IDA annotation for phosphate ion transmembrane transport, from proteoliposome assays
      showing Pi uptake as the counter-substrate of the G6P:Pi antiport.
    action: KEEP_AS_NON_CORE
    reason: >-
      Pi transport is directly measured but represents the counter-transport leg of the
      antiporter; the G6P-directed function is the physiologically core role. Keep as
      non-core.
    supported_by:
    - reference_id: PMID:18337460
      supporting_text: >-
        our results suggest that G6PT has a dual role as a G6P and a P(i)
- term:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  evidence_type: IDA
  original_reference_id: PMID:21949678
  qualifier: enables
  review:
    summary: >-
      IDA annotation for the G6P:Pi antiporter activity from reconstituted proteoliposomes;
      G6PT is the physiological ER G6P antiporter that couples to glucose-6-phosphatase-α.
    action: ACCEPT
    reason: >-
      Direct biochemical demonstration of the defining antiporter activity, including CHA
      sensitivity and coupling to G6Pase-α that distinguishes G6PT from other SLC37
      members. Core function.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        Taken together these findings suggest that only SCL37A4 contributes to interprandial blood glucose homeostasis
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  qualifier: located_in
  review:
    summary: >-
      High-throughput direct assay (membrane proteomics of an NK-like cell line) detecting
      SLC37A4 in the membrane fraction. Confirms membrane association but is unspecific.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      A proteomics hit to the generic "membrane" term adds nothing beyond the specific,
      experimentally established ER membrane localization. Over-annotation (kept, not
      removed).
    supported_by:
    - reference_id: PMID:19946888
      supporting_text: >-
        approximately 40% of
        the identified proteins were predicted as plausible membrane proteins
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-3229118
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) annotation for ER membrane localization, consistent with all
      experimental localization data.
    action: ACCEPT
    reason: >-
      Correct core localization from an authoritative pathway source.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-198513
  qualifier: located_in
  review:
    summary: >-
      TAS (Reactome) annotation for ER membrane localization (G6P/Pi exchange reaction
      across the ER membrane).
    action: ACCEPT
    reason: >-
      Correct core localization; concordant with experimental data.
    supported_by:
    - reference_id: PMID:21949678
      supporting_text: >-
        The glucose-6-phosphate transporter (G6PT, also known as SLC37A4) is localized in the endoplasmic reticulum (ER) membrane
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: NAS
  original_reference_id: PMID:212064
  qualifier: located_in
  review:
    summary: >-
      NAS annotation to the general "endoplasmic reticulum" term, from an early
      description of a GSD type I variant attributed to a defect in the G6P transport
      system.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct compartment but less specific than the well-supported ER membrane term; the
      transporter is an integral membrane protein, so ER membrane is preferred. Keep as
      non-core / less specific.
    supported_by:
    - reference_id: PMID:212064
      supporting_text: >-
        A new variant of glycogen storage disease type I probably due to a defect in the
        glucose-6-phosphate transport system
- term:
    id: GO:0006006
    label: glucose metabolic process
  evidence_type: NAS
  original_reference_id: PMID:9428641
  qualifier: involved_in
  review:
    summary: >-
      NAS annotation to the broad "glucose metabolic process" term. SLC37A4 participates in
      glucose metabolism by supplying G6P for hydrolysis to glucose, but this is a very
      general process term.
    action: KEEP_AS_NON_CORE
    reason: >-
      True but broad; the specific G6P transport and glucose homeostasis terms capture the
      informative process roles. Keep as non-core parent.
    supported_by:
    - reference_id: PMID:9428641
      supporting_text: >-
        most likely the glucose 6-phosphate translocase that is
- term:
    id: GO:0015152
    label: glucose-6-phosphate transmembrane transporter activity
  evidence_type: IMP
  original_reference_id: PMID:12560945
  qualifier: enables
  review:
    summary: >-
      IMP annotation for glucose-6-phosphate transmembrane transporter activity; mutations
      in the transporter's signature motif abolish microsomal G6P uptake, showing the
      motif is required for G6P transport.
    action: ACCEPT
    reason: >-
      Mutational evidence directly supports G6P transmembrane transporter activity. This
      is a correct, informative MF term (a close, slightly less specific companion to the
      G6P:Pi antiporter term). Core function.
    supported_by:
    - reference_id: PMID:12560945
      supporting_text: >-
        the signature motif is a
- term:
    id: GO:0015152
    label: glucose-6-phosphate transmembrane transporter activity
  evidence_type: IDA
  original_reference_id: PMID:11140953
  qualifier: enables
  isoform: O43826-2
  review:
    summary: >-
      IDA annotation (on isoform 2, the variant vG6PT) for glucose-6-phosphate
      transmembrane transporter activity; vG6PT is active in microsomal G6P transport. The
      isoform field records what was assayed, not an isoform-unique function.
    action: ACCEPT
    reason: >-
      Direct demonstration that isoform 2 also transports G6P confirms the MF and shows the
      exon-7 luminal-loop insertion does not impair transport. Core function (isoform 2).
    supported_by:
    - reference_id: PMID:11140953
      supporting_text: >-
        vG6PT is also active in microsomal G6P
- term:
    id: GO:0015760
    label: glucose-6-phosphate transport
  evidence_type: IMP
  original_reference_id: PMID:12560945
  qualifier: involved_in
  review:
    summary: >-
      IMP annotation for glucose-6-phosphate transport; signature-motif mutants lack
      microsomal G6P uptake, implicating SLC37A4 in the transport process.
    action: ACCEPT
    reason: >-
      Mutational evidence supports the core G6P transport process. Core.
    supported_by:
    - reference_id: PMID:12560945
      supporting_text: >-
        required for microsomal glucose-6-phosphate transport
- term:
    id: GO:0015760
    label: glucose-6-phosphate transport
  evidence_type: IDA
  original_reference_id: PMID:11140953
  qualifier: involved_in
  isoform: O43826-2
  review:
    summary: >-
      IDA annotation (on isoform 2/vG6PT) for glucose-6-phosphate transport; the variant
      isoform is active in microsomal G6P transport.
    action: ACCEPT
    reason: >-
      Direct evidence that isoform 2 carries out G6P transport. Core process (isoform 2);
      not a unique isoform function.
    supported_by:
    - reference_id: PMID:11140953
      supporting_text: >-
        vG6PT is also active in microsomal G6P
- term:
    id: GO:0016020
    label: membrane
  evidence_type: NAS
  original_reference_id: PMID:9428641
  qualifier: located_in
  review:
    summary: >-
      NAS annotation to the generic "membrane" term based on the original cloning of a
      transmembrane protein with a C-terminal ER retention motif.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The generic membrane term is subsumed by the specific ER membrane localization
      (the same paper notes the ER retention motif). Over-annotation.
    supported_by:
    - reference_id: PMID:9428641
      supporting_text: >-
        presents at its carboxy terminus the consensus motif for retention in the
- term:
    id: GO:0042593
    label: glucose homeostasis
  evidence_type: IDA
  original_reference_id: PMID:11140953
  qualifier: involved_in
  isoform: O43826-2
  review:
    summary: >-
      IDA annotation (on isoform 2/vG6PT) for glucose homeostasis; the G6P transporter
      works together with glucose-6-phosphatase to maintain glucose homeostasis.
    action: ACCEPT
    reason: >-
      SLC37A4/G6PT has a central, experimentally supported role in interprandial
      blood-glucose homeostasis by supplying G6P for hydrolysis to glucose. A core
      physiological process for this gene.
    supported_by:
    - reference_id: PMID:11140953
      supporting_text: >-
        which works together with glucose-6-phosphatase to maintain glucose homeostasis
core_functions:
- description: >-
    Glucose-6-phosphate:inorganic-phosphate antiport across the endoplasmic reticulum
    membrane, moving cytosolic glucose-6-phosphate into the ER lumen in exchange for
    luminal inorganic phosphate.
  molecular_function:
    id: GO:0061513
    label: glucose 6-phosphate:phosphate antiporter activity
  directly_involved_in:
  - id: GO:0015760
    label: glucose-6-phosphate transport
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  supported_by:
  - reference_id: PMID:18337460
    supporting_text: >-
      our results suggest that G6PT has a dual role as a G6P and a P(i)
  - reference_id: PMID:21949678
    supporting_text: >-
      The primary function of G6PT is to translocate G6P from the cytoplasm into the lumen of the ER for hydrolysis into glucose and Pi
- description: >-
    Glucose-6-phosphate transmembrane transport into the ER, delivering G6P substrate to
    the luminal glucose-6-phosphatase catalytic subunits and thereby supporting
    interprandial blood-glucose homeostasis (terminal step of gluconeogenesis and
    glycogenolysis).
  molecular_function:
    id: GO:0015152
    label: glucose-6-phosphate transmembrane transporter activity
  directly_involved_in:
  - id: GO:0042593
    label: glucose homeostasis
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  supported_by:
  - reference_id: PMID:12560945
    supporting_text: >-
      required for microsomal glucose-6-phosphate transport
  - reference_id: PMID:21949678
    supporting_text: >-
      Together, the G6PT/G6Pase-α complex maintains interprandial glucose homeostasis
proposed_new_terms: []
suggested_questions:
- question: >-
    Beyond the hepatic G6PC1 axis, how does G6PT (with the ubiquitous G6PC3) support
    neutrophil function, and what molecular mechanism links the transporter defect to
    neutropenia and neutrophil dysfunction in GSD Ib?
- question: >-
    Do the two SLC37A4 isoforms (canonical vs vG6PT) differ in tissue-specific
    regulation or kinetics despite both being active G6P transporters?
suggested_experiments:
- description: >-
    Cryo-EM/functional dissection of the G6P:Pi antiport cycle to define the
    stoichiometry and the residues gating G6P entry versus Pi counter-transport (building
    on the 2025 structures), and test how GSD Ib missense variants perturb each half-cycle.
- description: >-
    Cell-based assays coupling G6PT with G6PC1 versus G6PC3 to quantify how the
    transporter partitions between the hepatic gluconeogenic and the neutrophil
    (energy/1,5-anhydroglucitol-6-phosphate detox) systems.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: PMID:10026167
  title: Inactivation of the glucose 6-phosphate transporter causes glycogen storage
    disease type 1b.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Foundational functional characterization of recombinant G6PT; establishes that
      GSD-1b mutations disrupt G6P transport. Directly supports the antiporter/transport
      annotations.
- id: PMID:11140953
  title: Human variant glucose-6-phosphate transporter is active in microsomal transport.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Shows isoform 2 (vG6PT) is an active microsomal G6P transporter working with
      glucose-6-phosphatase for glucose homeostasis; source of the isoform-2 annotations.
- id: PMID:12560945
  title: The signature motif in human glucose-6-phosphate transporter is essential
    for microsomal transport of glucose-6-phosphate.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Signature-motif mutants lack microsomal G6P uptake; supports G6P transmembrane
      transporter activity and the G6P transport process.
- id: PMID:18337460
  title: The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient
    in glycogen storage disease type Ib and Ic.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Reconstituted-proteoliposome demonstration of the dual G6P/Pi antiport function and
      that GSD-Ib and GSD-Ic map to the same G6PT gene. Primary support for GO:0061513.
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput membrane proteomics of an NK-like cell line; only supports the
      generic "membrane" term, which is subsumed by the specific ER membrane localization.
- id: PMID:212064
  title: A new variant of glycogen storage disease type I probably due to a defect
    in the glucose-6-phosphate transport system.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Early clinical description of a GSD type I variant attributed to defective G6P
      transport; historical support for the ER/transport role.
- id: PMID:21949678
  title: SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Although the title foregrounds SLC37A1/A2, the full text extensively characterizes
      G6PT/SLC37A4 as the physiological ER G6P:Pi antiporter (positive control), including
      CHA sensitivity, coupling to G6Pase-α, and ER localization. Strongly supports the
      SLC37A4 MF, BP and CC annotations.
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      HuRI high-throughput Y2H interactome; source of the bare "protein binding" (BIK)
      IPI. No established functional consequence for the antiporter; flagged as
      over-annotated.
- id: PMID:32884905
  title: 'SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the
    Golgi causes a new congenital disorder of glycosylation.'
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Establishes ER localization of wild-type SLC37A4 and that the dominant R423*
      variant mislocalizes to the Golgi causing CDG-IIw. Supports ER membrane localization.
- id: PMID:33964207
  title: A mutation in SLC37A4 causes a dominantly inherited congenital disorder of
    glycosylation characterized by liver dysfunction.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Describes SLC37A4 as an ER-localized multitransmembrane protein required for
      transporting G6P into the ER; the dominant CDG variant. Supports transport and ER
      membrane annotations.
- id: PMID:9428641
  title: Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen
    storage disease type Ib.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Original cDNA cloning; identifies the protein as the G6P translocase functionally
      associated with glucose-6-phosphatase, with a C-terminal ER retention motif.
- id: Reactome:R-HSA-198513
  title: 'SLC7A4 exchanges G6P for Pi across the ER membrane '
  findings: []
- id: Reactome:R-HSA-3229118
  title: Defective SLC37A4 does not exchange G6P and Pi across the ER membrane
  findings: []
- id: Reactome:R-HSA-70263
  title: Gluconeogenesis
  findings: []